OPINION
Published on 09 Feb 2024
Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1)
doi 10.3389/fmed.2023.1304718
- 818 views
- Frontiers in Medicine
- Nuclear Medicine
- Research Topics
- Women in Science - Nuclear Medicine 2024
Women in Science - Nuclear Medicine 2024
1,061
Total downloads
4,940
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 17 Jan 2024
Change of glucometabolic activity per PSMA expression predicts survival in mCRPC patients non-responding to PSMA radioligand therapy: introducing a novel dual imaging biomarker
doi 10.3389/fmed.2023.1339160
- 1,286 views
ORIGINAL RESEARCH
Published on 25 Jul 2023
ATN profile classification across two independent prospective cohorts
doi 10.3389/fmed.2023.1168470
- 1,618 views
- 1 citation
Published in
Frontiers in Medicine
- Nuclear Medicine
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.
Impact
- 4,940Topic views
- 3,260Article views
- 1,061Article downloads